Three-layered polyplex as a microRNA targeted delivery system for breast cancer gene therapy
Source abstract
Abstract
Abstract MicroRNAs (miRNAs), small non-coding RNAs, play an important role in modulating cell proliferation, migration, and differentiation. Since miRNAs can regulate multiple cancer-related genes simultaneously, regulating miRNAs could target a set of related oncogenic genes or pathways. Owing to their reduced immune response and low toxicity, miRNAs with small size and low molecular weight have become increasingly promising therapeutic drugs in cancer therapy. However, one of the major challenges of miRNAs-based cancer therapy is to achieve specific, effective, and safe delivery of therapeutic miRNAs into cancer cells. Here we provide a strategy using three-layered polyplex with folic acid as a targeting group to systemically deliver miR-210 into breast cancer cells, which results in breast cancer growth being inhibited.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
the Fourth Military Medical University
China University of Geosciences
Funding
Natural Science Foundation of Hubei Province · National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities, China University of Geosciences
References (46)
Show source-provided references
1. The evolution of gene regulation by transcription factors and microRNAs10.1038/nrg1990 ↗
2. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells10.1038/nature10661 ↗
3. miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth10.1038/ncomms9725 ↗
4. Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer10.1038/ncomms11418 ↗
5. MicroRNAs as novel regulators of angiogenesis10.1161/CIRCRESAHA.108.191270 ↗
6. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells10.1158/0008-5472.CAN-12-0271 ↗
7. Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer10.1007/s00432-010-0932-6 ↗
8. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients10.1007/s10585-010-9355-7 ↗
9. Regulation of immune responses and tolerance: the microRNA perspective10.1111/imr.12060 ↗
10. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy10.1016/j.actbio.2015.07.020 ↗
11. Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy10.1016/j.jconrel.2016.03.008 ↗
12. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA10.1016/j.biomaterials.2011.03.047 ↗
13. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma10.1016/j.jconrel.2012.01.014 ↗
14. Progress in microRNA delivery10.1016/j.jconrel.2013.09.015 ↗
15. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors10.1016/j.addr.2014.10.031 ↗
16. In vivo delivery of miRNAs for cancer therapy: challenges and strategies10.1016/j.addr.2014.05.009 ↗
17. Recent progress in delivery of cancer related microRNAs10.1166/jnn.2016.11360 ↗
18. Viral vectors in cancer immunotherapy: which vector for which strategy?10.2174/156652308784049345 ↗
19. Nonviral vectors for gene delivery10.1021/cr800409e ↗
20. Recent advances in nonviral vectors for gene delivery10.1021/ar200151m ↗
21. Non-viral vectors for gene-based therapy10.1038/nrg3763 ↗
22. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model10.1038/gt.2016.60 ↗
23. EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery10.1088/0957-4484/27/46/464001 ↗
24. Targeted delivery of microRNA-126 to vascular endothelial cells via REDV peptide modified PEG-trimethyl chitosan10.1039/C5BM00629E ↗
25. PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy10.1089/oli.2011.0278 ↗
26. Tumour micro environment—opinion—emerging roles of proteases in tumour suppression10.1038/nrc2228 ↗
27. Influence of tumour micro-environment heterogeneity on therapeutic response10.1038/nature12626 ↗
28. Improving drug delivery to solid tumors: priming the tumor microenvironment10.1016/j.jconrel.2014.12.018 ↗
29. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect10.1016/j.addr.2010.04.009 ↗
30. Tumor delivery of macromolecular drugs based on the EPR effect10.1016/j.addr.2010.03.011 ↗
31. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond10.1016/j.jconrel.2012.04.038 ↗
32. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo10.1016/j.addr.2012.10.002 ↗
33. Active targeting of brain tumors using nanocarriers10.1016/j.biomaterials.2007.06.011 ↗
34. Targeted drug delivery via folate receptors10.1517/17425247.5.3.309 ↗
35. The transferrin receptor and the targeted delivery of therapeutic agents against cancer10.1016/j.bbagen.2011.07.016 ↗
36. Targeting tumor antigens to dendritic cells using particulate carriers10.1016/j.jconrel.2012.05.010 ↗
37. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics10.1016/j.ejps.2012.12.006 ↗
38. Hyaluronic acid modified mesoporous carbon nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells10.1088/0957-4484/27/13/135102 ↗
39. Self-assembled nanoparticles comprising aptide-SN38 conjugates for use in targeted cancer therapy10.1088/0957-4484/27/48/48LT01 ↗
40. Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects10.1038/ncomms10376 ↗
41. Amphiphilic linear-hyperbranched polymer poly(ethylene glycol)-branched polyethylenimine-poly(ε-caprolactone): synthesis, self-assembly and application as stabilizer of platinum nanoparticles10.1002/pi.5118 ↗
42. A membrane effect of basic polymers dependent on molecular size10.1038/215934a0 ↗
43. Effect of surface properties on nanoparticle-cell interactions10.1002/smll.200901158 ↗
44. Gold nanoparticles stabilized by amphiphilic hyperbranched polymers for catalytic reduction of 4-nitrophenol10.1016/j.jcat.2016.01.014 ↗
45. Understanding nanoparticle cellular entry: a physicochemical perspective10.1016/j.cis.2015.01.007 ↗
46. Hypoxia-inducible miR-210 regulates normoxic gene expression involved in tumor initiation10.1016/j.molcel.2009.09.006 ↗